Literature DB >> 15229265

Chronic inflammatory demyelinating polyradiculoneuropathy with ataxia.

R C Stockdale1, C K Biswas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15229265      PMCID： PMC1079532          DOI： 10.1177/014107680409700713

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  5 in total

Review 1.  Diabetes mellitus and the nervous system.

Authors:  P J Watkins; P K Thomas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-11       Impact factor: 10.154

Review 2.  Intravenous immunoglobulin in neurological disease: a specialist review.

Authors:  C M Wiles; P Brown; H Chapel; R Guerrini; R A C Hughes; T D Martin; P McCrone; J Newsom-Davis; J Palace; J H Rees; M R Rose; N Scolding; A D B Webster
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

3.  P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  W X Yan; J J Archelos; H P Hartung; J D Pollard
Journal:  Ann Neurol       Date:  2001-09       Impact factor: 10.422

4.  [Ataxic neuropathy in the elderly--clinicopathological study of six cases].

Authors:  K Harada; N Ohkoshi; H Nagata; S Shoji
Journal:  Nihon Ronen Igakkai Zasshi       Date:  1997-08

5.  Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy?

Authors:  Margherita Capasso; Filomena Torrieri; Antonio Di Muzio; Maria Vittoria De Angelis; Alessandra Lugaresi; Antonino Uncini
Journal:  Clin Neurophysiol       Date:  2002-03       Impact factor: 3.708
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.